• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH

ALTERITY THERAPEUTICS LIMITED

7.14% ! 1.3¢
Market Cap $119.6M  !

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH
Stock price - ATH/ATHE
39 40 41
09:48 2.4K 784K
09:48 Last post  lovethespeccies Comments Created with Sketch.  2.4K  Views Created with Sketch.  784K 
ATH
Questions for upcoming Australian visit
05/08/25 18 4.7K
05/08/25 Last post  pivalde Comments Created with Sketch.  18  Views Created with Sketch.  4.7K 
ATH
Ferroptosis in health and diseases
05/08/25 0 348
05/08/25 Last post  pivalde Comments Created with Sketch.  0  Views Created with Sketch.  348 
ATH
News, articles and interviews
2 3 4
04/08/25 231 87K
04/08/25 Last post  andymonroe Comments Created with Sketch.  231  Views Created with Sketch.  87K 
ATH
Diseases with brain atrophy ?
04/08/25 11 2.7K
04/08/25 Last post  itsagas Comments Created with Sketch.  11  Views Created with Sketch.  2.7K 
ATH 04/08/25 3 1.3K
04/08/25 Last post  rakeshnirzari1 Comments Created with Sketch.  3  Views Created with Sketch.  1.3K 
ATH 04/08/25 105 22K
04/08/25 Last post  Tradeyoursoul Comments Created with Sketch.  105  Views Created with Sketch.  22K 
ATH 03/08/25 25 5.8K
03/08/25 Last post  itsagas Comments Created with Sketch.  25  Views Created with Sketch.  5.8K 

See All Discussions arrow Created with Sketch.

Timeline

Response to ASX Query Letters
04 Aug 12:42
 
Updated Corporate Presentation
31 Jul 08:47
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 10:13
 
Positive ATH434 Results from Open-Label Phase 2 Trial in MSA
28 Jul 09:59
 
Change in substantial holding
28 Jul 08:18
 
Peer-Reviewed Publication on Novel MRI Endpoint from bioMUSE
24 Jul 10:08
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.3¢
Change
-0.001(7.14%)
Mkt cap ! $119.6M
Open High Low Value Volume
1.4¢ 1.5¢ 1.3¢ $123.8K 8.854M

Buyers (Bids)

No. Vol. Price($)
36 22048002 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 980000 4
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.